Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Loses Neuroscience Chief To Johnson & Johnson

Related Content

Can Amyvid Be An Important Alzheimer's Product Without An Alzheimer's Indication?

Mar 14 2011

Lilly Continues To Bet On Alzheimer's With Avid Acquisition

Nov 08 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window